Loading...
News2019-02-08T15:19:04-05:00

NEWS FROM REVEN

04/03/2020|

FOR IMMEDIATE RELEASE Reven Announces Coronavirus Treatment Acceleration Program (CTAP) Submission to the FDA Golden, [...]

03/28/2020|

A Phase 1, Double-blind, Placebo-controlled, Randomized, Two-Part, Ascending Dose-escalation Study to Evaluate the Safety, Tolerability, [...]

03/23/2020|

Reven successfully completes Phase I clinical trials and is pleased to announce completion with no [...]

03/22/2020|

Reven announces Phase II Clinical Development plans for upcoming human efficacy trials.  These trials include [...]

03/21/2020|

Reven will soon kick off a social media campaign to get the word out about [...]